GleamWall
中文EN

CYRX Cryoport, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1124524 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.8%
TTM net income YoY-157.9%
TTM EPS YoY-178.6%
Revenue 3-yr CAGR-6.6%
Net income 3-yr CAGR—

Margins

Gross margin46.9%
Operating margin-20.0%
Net margin-21.5%
FCF margin-9.8%
EBITDA margin-6.6%

Returns

ROE-8.3%
ROA-5.4%
ROIC (approx.)-13.2%
Asset turnover0.25x

Leverage & solvency

Liabilities / assets35.6%
Debt / equity0.00x
Current ratio2.04x
Interest coverage-18.32x

Cash quality & payout

Operating cash flow / net income-0.27x
Accruals ratio-6.9%
Payout ratio—
Capex / revenue15.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$176.18M$156.77M
Cost of revenue$93.12M$87.11M
Gross profit$83.05M$69.66M
R&D expense$17.04M$17.71M
SG&A expense$102.82M$109.81M
Operating income-$36.81M-$121.67M
Interest expense$2.36M$3.98M
Pretax income-$32.17M-$104.35M
Income tax$1.80M$359,000
Net income$78.30M-$114.76M
EBITDA-$9.09M-$90.91M
EPS (basic)1.40-2.49
EPS (diluted)1.40-2.49
Weighted avg. shares (diluted)50.07M49.35M
Balance sheet
Cash & equivalents$250.49M$34.14M
Short-term investments$160.71M$216.46M
Receivables$33.36M$25.30M
Inventory$23.19M$21.48M
Current assets$476.17M$341.57M
PP&E, net$85.45M$80.01M
Goodwill$22.40M$20.57M
Intangibles$138.08M$147.93M
Total assets$764.99M$703.49M
Current liabilities$219.02M$64.56M
Total liabilities$262.35M$301.59M
Shareholders' equity$502.64M$401.90M
Shares outstanding49.85M49.91M
Cash flow statement
Operating cash flow-$8.58M-$16.32M
Capital expenditure$16.44M$17.25M
Free cash flow-$25.02M-$33.58M
Investing cash flow$250.32M$176.81M
Financing cash flow-$21.07M-$161.53M
Depreciation & amortization$27.71M$30.76M
Stock-based compensation$10.07M$16.57M
Share buybacks$10.01M—

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.